Gilead Sciences, Inc. (GILD) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 16:04 ET. Consensus EPS estimate is $2.15.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | FY2026 Q2 | $-7.25 | $-6.75 | +6.9% | $7.80B |
| 2026-05-07 | FY2026 Q1 | $1.91 | $2.03 | +6.3% | $6.96B |
| 2026-02-24 | FY2025 Q4 | $1.81 | $1.86 | +2.8% | $7.92B |
| 2025-11-07 | FY2025 Q3 | $2.13 | $2.46 | +15.5% | $7.77B |
| 2025-08-07 | FY2025 Q2 | $1.96 | $2.01 | +2.6% | $7.08B |
| 2025-05-07 | FY2025 Q1 | $1.78 | $1.81 | +1.7% | $6.67B |
| 2025-02-28 | FY2024 Q4 | $1.74 | $1.90 | +9.2% | $7.57B |
| 2024-11-12 | FY2024 Q3 | $1.53 | $2.02 | +32.0% | $7.54B |
GILD has beaten consensus EPS in 8 of its last 8 reported quarters.
See GILD on the live calendar →